LISBY; Steen
Patent Applications and Registrations
Patent applications and USPTO patent grants for LISBY; Steen.The latest application filed is for "dosing regimens for anti-tf-antibody drug-conjugates".
- LISBY; Steen - Hornbaek DK
- LISBY; Steen - Frederiksberg DK
- LISBY; Steen - Hornb.ae butted.k DK
| Patent | Date |
|---|---|
| Dosing Regimens For Anti-tf-antibody Drug-conjugates App 20220265844 - LISBY; Steen ; et al. | 2022-08-25 |
| Human Antibody Drug Conjugates Against Tissue Factor App 20210395384 - SATJIN; David ; et al. | 2021-12-23 |
| Anti-tissue Factor Antibody-drug Conjugates And Their Use In The Treatment Of Cancer App 20210177987 - RANGWALA; Reshma Abdulla ; et al. | 2021-06-17 |
| Combination Treatment Of Cd38-expressing Tumors App 20200114000 - VAN DE WINKEL; Jan ; et al. | 2020-04-16 |
| Human Antibody Drug Conjugates Against Tissue Factor App 20190315880 - SATIJN; David ; et al. | 2019-10-17 |
| New Dosage Regimens For Antibody Drug Conjugates Based On Anti-axl Antibodies App 20190233522 - FORSSMANN; Ulf ; et al. | 2019-08-01 |
| Dosing Regimens For Anti-tf-antibody Drug-conjugates App 20190030178 - LISBY; Steen ; et al. | 2019-01-31 |
| Human Antibodies And Antibody-drug Conjugates Against Cd74 App 20170173151 - VERPLOEGEN; Sandra ; et al. | 2017-06-22 |
| Human Antibody Drug Conjugates Against Tissue Factor App 20170136130 - SATIJN; David ; et al. | 2017-05-18 |
| Human antibodies and antibody-drug conjugates against CD74 Grant 9,540,433 - Verploegen , et al. January 10, 2 | 2017-01-10 |
| Human antibody drug conjugates against tissue factor Grant 9,492,565 - Satijn , et al. November 15, 2 | 2016-11-15 |
| Method of treating rash in patients undergoing anti-EGFR therapy Grant 9,428,582 - Edvardsen , et al. August 30, 2 | 2016-08-30 |
| Human Antibody Drug Conjugates Against Tissue Factor App 20160067349 - SATIJN; David ; et al. | 2016-03-10 |
| Human antibody drug conjugates against tissue factor Grant 9,168,314 - Satijn , et al. October 27, 2 | 2015-10-27 |
| Combination Treatment Of Cd38-expressing Tumors App 20150231235 - VAN DE WINKEL; Jan ; et al. | 2015-08-20 |
| Combination treatment of CD38-expressing tumors Grant 9,040,050 - Van De Winkel , et al. May 26, 2 | 2015-05-26 |
| Human Antibodies And Antibody-drug Conjugates Against Cd74 App 20140030273 - Verploegen; Sandra ; et al. | 2014-01-30 |
| Human Antibody Drug Conjugates Against Tissue Factor App 20130101608 - Satijn; David ; et al. | 2013-04-25 |
| CD20 Binding Molecules for the Treatment of Copd App 20130004480 - Parren; Paul ; et al. | 2013-01-03 |
| Prevention Of Rash In Patients Undergoing Anti-egfr Therapy App 20100150936 - Edvardsen; Klaus ; et al. | 2010-06-17 |
| Combination Treatment Of Cd38-expressing Tumors App 20100092489 - Van De Winkel; Jan ; et al. | 2010-04-15 |
| SEC | 0001753152 | Lisby Steen |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 